RemeGen Co Ltd
SSE:688331
RemeGen Co Ltd
SSE:688331
Price:
99
CNY
-2.46%
Market Cap:
¥55.8B
Balance Sheet
Balance Sheet Decomposition
RemeGen Co Ltd
RemeGen Co Ltd
Balance Sheet Decomposition is not available for
RemeGen Co Ltd
RemeGen Co Ltd
Balance Sheet
RemeGen Co Ltd
RemeGen Co Ltd
Currency: CNY
| Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Cash Equivalents |
5
|
35
|
2 769
|
1 757
|
2 069
|
727
|
760
|
|
| Cash |
0
|
0
|
0
|
0
|
2 067
|
726
|
760
|
|
| Cash Equivalents |
5
|
35
|
2 769
|
1 757
|
2
|
0
|
0
|
|
| Total Receivables |
15
|
18
|
36
|
36
|
303
|
473
|
626
|
|
| Accounts Receivables |
11
|
1
|
0
|
7
|
202
|
298
|
383
|
|
| Other Receivables |
4
|
17
|
36
|
29
|
101
|
176
|
243
|
|
| Inventory |
30
|
31
|
66
|
280
|
523
|
742
|
659
|
|
| Other Current Assets |
16
|
54
|
107
|
227
|
317
|
287
|
244
|
|
| Total Current Assets |
65
|
138
|
2 977
|
2 300
|
3 212
|
2 229
|
2 290
|
|
| PP&E Net |
398
|
471
|
941
|
1 727
|
2 663
|
3 036
|
2 975
|
|
| PP&E Gross |
398
|
471
|
941
|
1 727
|
2 663
|
3 036
|
2 975
|
|
| Accumulated Depreciation |
63
|
103
|
150
|
214
|
469
|
699
|
980
|
|
| Intangible Assets |
3
|
2
|
5
|
13
|
56
|
144
|
143
|
|
| Note Receivable |
31
|
48
|
61
|
55
|
0
|
0
|
0
|
|
| Long-Term Investments |
10
|
11
|
13
|
12
|
81
|
98
|
72
|
|
| Other Long-Term Assets |
24
|
20
|
121
|
53
|
9
|
21
|
18
|
|
| Total Assets |
531
N/A
|
689
+30%
|
4 118
+497%
|
4 159
+1%
|
6 021
+45%
|
5 528
-8%
|
5 499
-1%
|
|
| Liabilities | ||||||||
| Accounts Payable |
17
|
68
|
63
|
159
|
109
|
125
|
162
|
|
| Accrued Liabilities |
16
|
29
|
59
|
114
|
138
|
224
|
287
|
|
| Short-Term Debt |
0
|
60
|
108
|
0
|
122
|
301
|
1 090
|
|
| Current Portion of Long-Term Debt |
1
|
2
|
43
|
53
|
60
|
60
|
349
|
|
| Other Current Liabilities |
964
|
698
|
159
|
290
|
448
|
417
|
290
|
|
| Total Current Liabilities |
997
|
857
|
431
|
616
|
877
|
1 128
|
2 178
|
|
| Long-Term Debt |
3
|
4
|
47
|
50
|
105
|
915
|
1 238
|
|
| Deferred Income Tax |
0
|
0
|
1
|
0
|
0
|
2
|
0
|
|
| Other Liabilities |
29
|
61
|
45
|
46
|
59
|
46
|
96
|
|
| Total Liabilities |
1 029
N/A
|
921
-10%
|
523
-43%
|
713
+36%
|
1 041
+46%
|
2 091
+101%
|
3 512
+68%
|
|
| Equity | ||||||||
| Common Stock |
0
|
0
|
490
|
490
|
544
|
544
|
544
|
|
| Retained Earnings |
568
|
402
|
605
|
310
|
1 342
|
2 854
|
4 322
|
|
| Additional Paid In Capital |
70
|
169
|
3 709
|
3 709
|
6 233
|
6 238
|
6 291
|
|
| Unrealized Security Profit/Loss |
0
|
1
|
1
|
0
|
1
|
58
|
91
|
|
| Treasury Stock |
0
|
0
|
0
|
449
|
463
|
440
|
445
|
|
| Other Equity |
0
|
0
|
0
|
6
|
9
|
7
|
9
|
|
| Total Equity |
498
N/A
|
232
+53%
|
3 595
N/A
|
3 446
-4%
|
4 980
+45%
|
3 437
-31%
|
1 986
-42%
|
|
| Total Liabilities & Equity |
531
N/A
|
689
+30%
|
4 118
+497%
|
4 159
+1%
|
6 021
+45%
|
5 528
-8%
|
5 499
-1%
|
|
| Shares Outstanding | ||||||||
| Common Shares Outstanding |
478
|
478
|
490
|
490
|
539
|
538
|
544
|
|
Switch to:
Switch to:
See Also
Discover More
